APC	Allophycocyanin
AUC	Curve with corresponding area under the curve
CR	Complete response
DCR	Disease control rate
EV	Extracellular vesicle
FASP	Filter-aided sample preparation
FMO	Fluorescence minus one
iBAQ	Intensity-based absolute quantification
ICI	Immune checkpoint inhibitor
IDO	Indoleamine 2,3-dioxygenase
IPA	Ingenuity Pathway Analysis
LC-MS/MS	Liquid chromatography tandem mass spectrometry
LCD	Lipophilic cationic dye
MBR	Match-between-runs
mOS	Median overall survival
NRB	Non-Responders at baseline
NRP	Non-responders post-treatment
NSCLC	Non-small cell lung cancer
PD-1	Programmed cell death 1
PD-L1	Programmed cell death-ligand 1
PD	Progressive disease
PECAM-1	Platelet endothelial adhesion molecule-1
PFC	Polychromatic flow cytometry
PR	Partial response
RB	Responders at baseline
ROC	Receiving operator characteristic
RP	Responders post-treatment;
SD	Stable disease;
TME	Tumor microenvironment;
URA	Upstream Regulator Analysis;
VEGF	Vascular endothelial growth factor;